Who actually makes compounded GLP-1s

Empower runs a 503A division alongside the largest 503B outsourcing facility registered with the FDA in the United States. The Houston company is cGMP-compliant. Compounded semaglutide and tirzepatide from it feed many of the biggest telehealth brands in the country.

Lakewood, Colorado is the base for this compounder, which now trades under the name Belmar Pharma Solutions. Founded in 1985 and nationally recognized, it runs both a 503A and a 503B facility, and its shipping licensure reaches all 50 states. PCAB accreditation is on file.

Orlando, Florida. Olympia holds dual 503A and 503B status, with FDA registration as an outsourcing facility. Sterile injectable compounds are its output, GLP-1 medications among them.

Kennesaw, Georgia. A family-owned operation at its 2007 founding, Innovation Compounding is a 503A pharmacy acquired by Revelation Pharma in January 2022. ACHC granted it PCAB accreditation in June 2024. Its published list covers 47 states and DC; California gets nonsterile preparations only.

Gilbert, Arizona hosts Strive Pharmacy, a 503A compounder. It holds PCAB, NABP and LegitScript accreditation, and carries licenses in all 50 states. Several direct-to-consumer telehealth brands buy its compounded GLP-1 medications.

Absolute Pharmacy, a Lutz, Florida 503A, holds LegitScript Healthcare Merchant certification dated Sept 15, 2021, and may fulfill prescriptions in 49 states. A proprietary eRX software automates state-licensing checks for telehealth prescribers. Express compounded prescription fulfillment is the specialty: weight loss using semaglutide and tirzepatide, plus sleep, anxiety, fertility, hair loss, sexual health, and hormone replacement.

Shields Pharmacy, Dunedin, Florida: LegitScript-certified and PCAB-accredited for sterile and non-sterile compounding, holding Florida pharmacy license PH32060. Its state map shows 19 states it serves, plus Puerto Rico, and it says more than 5,000 providers use it.

PCAB accreditation at MediVera Compounding Pharmacy (operated by Diversified Pharmacy, Inc.) covers sterile and non-sterile compounding both, a dual accreditation it says fewer than 1% of US compounders hold. This Troy, MI 503A at 5225 Crooks Rd says it is licensed across 49 states and invests in third-party testing. Its weight-management page lists compounded liraglutide and sermorelin as the medications currently available; it no longer lists semaglutide or tirzepatide.

Wells Pharmacy Network runs a 503A compounding pharmacy in Ocala, Florida and an FDA-registered 503B outsourcing facility in Dyersburg, Tennessee. Its focus is hormone compounding, weight management and wellness.

Hallandale Pharmacy (Pharmcore Inc.) is a Florida 503A compounder that now works out of Fort Lauderdale, where it moved its sterile compounding in 2018. A 2020 FDA warning letter cited insanitary conditions at its former Hallandale site; FDA closed that letter out in 2022. Its sterile line includes GLP-1 medications.

State-licensed in Utah as a 503A compounder, Red Rock keeps locations in Springville and St. George. Sterile injectables come out of it, compounded semaglutide and tirzepatide among them.

Revelation Pharma, based in Kennesaw, Georgia, runs a network of more than 20 compounding pharmacies built largely by acquisition. Its 503B outsourcing arm is Eagle Pharma Outsourcing in Hoover, Alabama; the rest are 503A pharmacies. The network supplies sterile compounds, GLP-1 medications among them.

Irvine Sand Canyon Pharmacy Inc. owns Town Center Compounding & Rx Pharmacy, small and independent, holder of California compounding pharmacy license #99148, at Suite A-1, 72624 El Paseo, in Palm Desert, CA 92260. RECOMMENDED FOR REMOVAL: nothing found shows that it compounds GLP-1 medications, or that it ships across state lines.

Sultan Haroon and Maja Matthews founded Epiq Scripts, a Richardson, TX mail-order compounding pharmacy, in 2022. It presents itself as an API-driven, white-label 503A partner for telehealth brands, with high-volume prescription fulfillment, custom-branded packaging, UPS shipping, and custom compounding both sterile and non-sterile, GLP-1 medications included. Certification by LegitScript is attested in a 2025 LegitScript customer-spotlight Q&A featuring co-founder Haroon.

Nothing compounded here: this national mail-order pharmacy dispenses brand-name FDA-approved GLP-1 medications. With the manufacturer coupon, cash prices start at $149 a month for the Foundayo and Wegovy pills, $299 for the Zepbound KwikPen at 2.5 mg, $349 for the Wegovy pen at 2.4 mg and $499 for the single-dose Zepbound pen. Insured patients may pay as little as $25. It is one of the pharmacies that fill LillyDirect orders. It ships to all 50 states, with same-day delivery in many cities, and Amazon One Medical runs a GLP-1 care program alongside it.

Atlanta, Georgia, 1999: that is where and when Pavilion Compounding Pharmacy started as a 503A. PCAB accreditation is held, and per the company website, licenses in 7 states. Compounded prescriptions are the business, among them GLP-1 medications and bioidentical hormone pellets sold as SteriPellets.

Peptide and hormone compounding are the specialties of Tailor Made Compounding, a 503A, and it has been notable as a supplier of compounded GLP-1 medications. Nicholasville, Kentucky is the address; earlier reports placing it in Lexington were wrong.

Costco Pharmacy, the membership warehouse's retail pharmacy, dispenses brand-name GLP-1 medications, not compounded ones. Through Member Value Pricing, a member with a prescription pays Novo Nordisk's cash prices: Wegovy or Ozempic tablets $149 to $299 a month by dose, Wegovy or Ozempic pens $199 for the first two fills at the lowest doses and then $349, Wegovy HD $399 and Ozempic 2 mg $499. Lilly drugs cost far more here than direct from Lilly: the Zepbound KwikPen is about $499 to $699 and Foundayo about $649. Insurance claims cannot use these prices.

Branded FDA-approved GLP-1 medications only, never compounded ones, across this national retail pharmacy. Novo Nordisk's self-pay program puts branded semaglutide, sold as Wegovy or Ozempic, at self-pay prices of about $349/month for injections and roughly $149/month for oral tablets. A partnership with Eli Lilly adds single-dose vials of Zepbound (tirzepatide), dispensed at Walmart pharmacies or by home delivery. Its Better Care Services arm runs a GLP-1 care platform offering virtual care and nutrition support.

Texas-based, and the 503B arm of the FarmaKeio Pharmacy Network, registered with FDA. Sterile work is the output here, including combinations built on semaglutide and tirzepatide. It holds licenses across 49 states, Puerto Rico and the U.S. Virgin Islands. It is also litigating: FarmaKeio leads a suit, with the Outsourcing Facilities Association beside it, against FDA's decision to take tirzepatide off the shortage list.

Founded in 2003 at Egg Harbor Township, New Jersey, Curexa holds PCAB accreditation and LegitScript certification as a 503A. Its compounding includes GLP-1 weight-loss medications such as tirzepatide and semaglutide. Telehealth platforms name it frequently as their back-end fulfillment pharmacy.

Folcroft, PA, near Philadelphia, is home to Chemistry Rx. Accreditation comes from PCAB, ACHC and URAC, and the business runs as a 503A compounding and specialty pharmacy. GLP-1 medications are compounded for telehealth partners. Marketing points to 503B-scale capabilities, but it is operated as a 503A compounder.

Open since 2018 at Suite 200, 7810 Eldorado Parkway, McKinney, TX 75070, Beaker is independent and does retail alongside sterile compounding. Output covers hormones, pediatric formulations, dermatology preparations, other specialty compounds, and GLP-1 medications in the form of semaglutide and tirzepatide. Reported coverage is 45+ states.

Walmart owns this national membership-warehouse retail pharmacy, which dispenses branded FDA-approved GLP-1 medications, not compounded ones. Its pharmacy page advertises GLP-1 medications "as low as $25" with insurance or $149 without insurance, and Zepbound (tirzepatide) KwikPen starting at $299. Plus members get free pharmacy delivery.

Katy, Texas, at 1330 Pin Oak Rd, 77494. Striker Pharmacy LLC is a 503A sterile compounding pharmacy with LegitScript certification, Healthcare Merchant Certification ID 20748291. Its specialty is compounded GLP-1 therapies for licensed prescribers, meaning semaglutide and tirzepatide. The model is built around B2B: doctors and patients fill in separate intake forms, and medical practices can buy wholesale supply.

Palm Harbor, Florida, LegitScript-certified, 503A: Promise Pharmacy, at 31818 US Hwy 19 N. Clinics, med spas and telehealth providers order patient-specific compounded medications through one portal; it lists weight management among its therapy areas and says it ships to 41 states and Washington, D.C. USP 795/797/800 standards are followed. FDA issued it a warning letter in 2019 and closed it out in 2022 with a referral to the Florida Board of Pharmacy. Note: FDA shortage resolution restricts routine 503A compounding of GLP-1s that duplicate commercially available products.

Inside the Texas-based FarmaKeio Pharmacy Network, this is the patient-specific 503A compounding pharmacy. Custom formulations come sterile and non-sterile, among them semaglutide and tirzepatide combinations for weight management. FarmaKeio publishes its licensure for the network as a whole, not for this pharmacy on its own.

For over 20 years Skip's Pharmacy, a Deerfield Beach, Florida 503A, has served the low-dose-naltrexone, autoimmune and MS communities. It also compounds GLP-1 weight-loss medications, semaglutide and tirzepatide included, for human and veterinary patients.

Stafford, Texas is the site of Casa Pharma RX, a licensed 503A sterile compounding pharmacy. Its cleanroom meets USP 797 and USP 800 standards, and APIs come exclusively from FDA-registered suppliers. Several GLP-1 telehealth platforms name it as a pharmacy partner; compounded semaglutide and tirzepatide are what it offers.

Franklin, TN, and among the largest 503A compounding pharmacies in Tennessee, DCA's own shipping page lists 49 states and DC (all but South Carolina), though its heading gives a lower count. Its lines are pellet therapy, scar therapy, topical pain management, bio-identical hormone replacement, and sterile compounding. Novo Nordisk named the pharmacy in a 2023 lawsuit over compounded semaglutide; that case ended in a voluntary dismissal.

GLP-1 therapies, tirzepatide and semaglutide included, come out of SmartPharmaRX, a 503A licensed compounding pharmacy. Sterile preparations are made under cGMP-aligned protocols in accordance with USP 797, and aligned to USP 795 / 800 as well. Ahead of release, each preparation is tested for stability, endotoxin, potency and sterility. Where it is licensed stays vague: the public site says only 'select states' and enumerates none.

A 55,200 sq ft facility in Houston, Texas houses SouthEnd Pharmacy, LegitScript-certified and 503A, a sterile compounder whose coverage map shows 40 states plus DC, with next-day cold-chain delivery. Semaglutide and tirzepatide are compounded with B6/pyridoxine. APIs are sourced only from manufacturers registered with the FDA.

ReviveRX, founded 2016 at 3831 Golf Dr., 77018, Houston, Texas, is a mail-order 503A that began compounding in 2018 and ships to 44 states plus Puerto Rico. It bills no insurance, working through a provider portal. Advertised categories: 'Weight Loss' and 'Peptide & Longevity' beside hormone, sexual wellness and dermatology preparations. Self-attested: FDA-registered vendor procurement, USP-compliant clean rooms both sterile and non-sterile, a 'successful FDA inspection.' No LegitScript or PCAB accreditation badge is displayed, and GLP-1 drug names sit behind the provider-portal login.

Houston, Texas. License #35264 from the Texas State Board of Pharmacy covers VialsRx, a 503A community sterile compounding pharmacy. Semaglutide and tirzepatide (GLP-1) are prepared under USP <797> sterile-compounding standards against an individual prescription. Note: 503A pharmacies face restrictions on routinely compounding GLP-1 duplicates of commercially available products now that FDA shortages are over.

Fairfax, Virginia is home to TruMedsRx (TMRX), which is LegitScript-certified and runs a 503A mail-order sterile compounding operation, its USP-compliant cleanroom facilities serving over 85,000 patients. Telehealth provider Enhance MD names it publicly, with Rite-Away and Vios, as one of three 503A pharmacy partners supplying compounded GLP-1, meaning semaglutide and tirzepatide; reportedly it carries no disciplinary history. Note: restrictions now cover routine 503A compounding of GLP-1 copies of commercially available drugs, the FDA shortages having been resolved.

Tomball, Texas. Greenwich Rx (Greenwich Health & Wellness LLC, 9733 FM 2920 Rd, Suite 100) operates as a 503A compounding pharmacy making sterile and non-sterile preparations under USP 795 and 797 and lot-testing them through an independent laboratory. It holds a Texas resident pharmacy license and says whether it can serve patients outside Texas depends on each state's law. An FDA Form 483 from a September 2026 inspection lists compounded semaglutide and tirzepatide preparations, and in October 2026 it recalled compounded glutathione for elevated endotoxin. Note: since the FDA shortages ended, routine 503A production of GLP-1s that copy commercial products is restricted.

Austin, Texas, established in 2007: Stonegate Pharmacy, a 503A compounder. Its GLP-1 medications, semaglutide and tirzepatide, are made as once-weekly subcutaneous injectables and as sublingual rapid-dissolving tablets. A 2019 inspection noted sterile-practice deviations, and an FDA State Referral Letter followed in 2020.

Largo, Florida. Belcher Pharmaceuticals owns it, and FDA registers it both as a drug manufacturer and as a 503B outsourcing facility. Injectable semaglutide and tirzepatide were made here at scale for telehealth brands, and Belle Health's own pharmacy list still names it as the maker of its tirzepatide. FDA has since moved to strike both molecules from the 503B bulk-drug list.

Las Vegas, Nevada. Partell Specialty Pharmacy operates as a 503A compounding and specialty pharmacy, offering sterile and non-sterile compounding that takes in GLP-1 medications for telehealth partners.

Glendale, California. Enovex Compounding Pharmacy, a 503A, handles sterile and non-sterile compounding, and the GLP-1 medications it compounds go to telehealth weight-loss partners.

Valiant Pharmacy Holdings operates Valiant Rx, a 503A compounding pharmacy in Ypsilanti, Michigan. Sublingual and oral forms of semaglutide, tirzepatide and liraglutide are compounded there for telehealth weight-loss partners.

Prescriptions written on the telehealth platform Ro are filled by Roman Health Pharmacy LLC, the affiliated mail-order pharmacy. Ro patients can receive medications from it, GLP-1 prescriptions included.

Hims & Hers acquired Apostrophe Pharmacy LLC in 2021, and the Gilbert, Arizona operation now runs as a subsidiary and dedicated mail-order pharmacy, providing prescription fulfillment for Hims & Hers customers.

MedisourceRx is a 503B outsourcing facility in Los Alamitos, California, registered with the FDA since 2017. Hims & Hers bought it in September 2024. The FDA issued it a Warning Letter in December 2025 after a 2025 inspection, and closed that letter out in July 2026.

Drug Depot Inc. trades as APS Pharmacy, a 503A compounding pharmacy in Palm Harbor, Florida with PCAB accreditation. It is listed as producing compounded semaglutide.

Greer, South Carolina is the address of Manifest Pharmacy, a mail-order pharmacy that fills prescriptions for telehealth programs and ships them to patients' homes. Its own site says it is licensed in and ships to all 50 states and Washington, DC, and it displays LegitScript and NABP badges. It does not describe itself as a compounding pharmacy or say which preparations it makes itself.

Christopher Quintana owns Optimal Balance Pharmacy, a 503A sterile compounder operating as OBPRX from Ste F&G, 2204 Cypress Creek Pkwy, Houston, TX 77090, NPI 1306535307. Inspections have come through the NABP Verified Pharmacy Program (VPP) and from the Texas State Board of Pharmacy. It is USP <795>/<797>/<800> compliant and sources API as a PCCA member. GLP-1 compounding is listed among its sterile-lab specialties, yet as of 2026-05-25 no specific products are enumerated on its public website. Published only as an image, the licensure map yields no explicit state list.

Rush Pharmacy is a compounding pharmacy headquartered at #1121, 1977 Alafaya Trail, Oviedo, FL 32765, with a second listed location at 4690 McDermott Rd, Ste 177, Plano, TX 75024. It sells customized compounded medications and supplements across hair growth, sexual wellness, hormone and weight management categories, with 48-hour shipping. Its weight-management page names phentermine, topiramate and metformin; it does not name semaglutide or tirzepatide. Both its homepage and its Where We Ship page say it is "pending licensure in all 50 states", and it publishes no state list. Bodyshop Wellness names it a pharmacy partner; listed here since 2026-05-28.

Rite-Away Pharmacy & Medical Supply covers San Antonio and Austin, Texas as a 503A doing sterile and non-sterile compounding. Telehealth provider Enhance MD publicly names it, with Vios and TruMedsRx, as one of three 503A pharmacy partners for compounded GLP-1; reportedly it carries no disciplinary history. Services run to retail prescriptions, infusions, long-term care, medical supplies, compounding both sterile and non-sterile, and free delivery. Note: the FDA shortages are resolved, which restricts routine compounding at 503A level of GLP-1s that duplicate commercial products.

Wells Pharma of Houston is registered with the FDA as a 503B outsourcing facility in Houston, Texas. Through the GLP-1 shortage era it compounded sterile injectables for clinics and providers, semaglutide and tirzepatide among them. An FDA Form 483 came in March 2025; an FDA Warning Letter followed in November 2025, both over 503B-compliance and sterility-assurance deficiencies. Legally it stands separate from Ocala, Florida's Wells Pharmacy Network.

Medwise Pharmacy is a 503A retail compounder in Plantation, FL, which sits in Broward, South Florida. Compounded semaglutide and tirzepatide are marketed directly to patients for weight management, in injectable and oral form. No public PCAB accreditation was found when this was reviewed.

CLYR Health names The Pharmacy Hub, a 503A compounding pharmacy, as the partner dispensing its compounded semaglutide and tirzepatide. The address is Suite C, 15600 NW 15th Ave, Miami, FL 33169.

Operator: Right Value Drug Stores, LLC, Texas. Its 503B outsourcing facility, FDA-registered July 3, 2019: Suite 190, 8400 Esters Blvd, Irving, TX 75063. The patient-specific 503A trades in Denton, TX as Carie Boyd's Prescription Shop, also listed at 122 Grapevine Hwy, Hurst, TX under NPPES NPI 1205253085 and Texas pharmacy license 165; roots: a 1965 community pharmacy in the Dallas-Fort Worth area. Sole GLP-1 weight management product: sublingual semaglutide suspension in a SubMagna sublingual base, compounded exclusively from commercially available Rybelsus tablets, titrated from a 1 mg/day starting dose to about 1.5 mg/day. No public marketing of compounded tirzepatide was found. FDA Warning Letters of December 17, 2024 (503B compliance and labeling deficiencies, reference 694687) and September 20, 2021 (reference 610751, after a 2019 inspection) reduce confidence for telehealth-provider sourcing versus peers with no active FDA enforcement on file.

Tailstorm Health Inc. does business as Medivant Healthcare and holds FDA registration as a 503B outsourcing facility in Chandler, Arizona. It sells sterile injectables to hospitals and clinics: anesthesia and critical-care drugs, testosterone cypionate prefilled syringes, NAD+ and repackaged bevacizumab. Its current product list names no semaglutide or tirzepatide, though it compounded both during the shortage. In April 2025 the FDA sent a warning letter citing cGMP and sterility violations and missing labeling on its GLP-1 products; FDA closed that letter out in March 2026, and a new Form 483 followed an August 2026 inspection.

iPharma Pharmacy is a licensed 503A at 5400 Katy Fwy, Ste 100, in Houston, TX, with certified clean rooms and a sterile-compounding lab. Compounding spans many areas: veterinary, dental, dermatology, HRT and weight loss. Its weight-loss pages now advertise compounded tirzepatide at $249 a month including a doctor consultation, alongside its in-house iSlimWell formula; no semaglutide is advertised. Licenses cover TX, AZ, IL, FL and NY, with sterile compounding in TX, AZ and NY.

Emerald Compounding Pharmacy is a Tampa, Florida compounder licensed by the Florida Department of Health for sterile and non-sterile compounding. Society of You and several other GLP-1 sellers name it as a dispensing partner. Its own site lists weight management among its services but does not name semaglutide or tirzepatide.

Tempe, Arizona, licensed across all 50 states: Foothills Professional Pharmacy is a 503A compounder. Its focus is weight-management compounding plus white-label telehealth fulfillment, semaglutide and tirzepatide included. In 2020 the FDA issued it a Warning Letter over compounding without patient-specific prescriptions.

Several GLP-1 telehealth programs name Triad Rx, a Daphne, Alabama 503A, as a state-licensed compounding partner, and it produces compounded semaglutide and tirzepatide. Despite the resemblance, it is a distinct business from Triad Compounding Pharmacy in California.

Enhance MD's pharmacy disclosures name Vios Compounding Pharmacy, a 503A in Livonia, Michigan, as a partner for GLP-1 compounding and fulfillment.

CloverX Pharmacy is a 503A that produces personalized compounded semaglutide and tirzepatide. No seller on our register names it as a fulfillment partner on its own site.

Weight-loss and wellness compounding is the focus of Mycelium Pharmacy, a 503A based in the Fort Lauderdale area of Florida, which ships GLP-1 medications on behalf of telehealth partners.

La Habra, California. Listings put compounded semaglutide and tirzepatide among the output of Central Drugs Compounding Pharmacy, a 503A.

University Compounding Pharmacy is a PCAB-accredited 503A in San Diego, California, compounding since 1993. Its site lists compounded semaglutide and tirzepatide, and it reports 46 state licenses.

Tampa, Florida. Rx Ave Health LLC, which also writes its name as RxAve Health, presents itself as a pharmacy fulfillment service for telehealth brands, backed by a network of more than 14 partner 503A pharmacies. Its federal provider (NPI) record lists it as a community/retail pharmacy. It publishes no list of the states where it is licensed and does not say which partner pharmacy compounds a given prescription.

SNF Holdings, LLC does business as Vios Compounding, a 503A in Livonia, Michigan. Its GLP-1 work covers semaglutide and tirzepatide, with injectable vials in 1 mL or 2.5 mL at 1 mg or 5 mg strength, plus GLP-1 oral strips and transmucosal films, each made against an individual prescription. April 2024 brought it a state referral letter from the FDA. Note: with FDA shortage status resolved, a 503A may no longer routinely compound GLP-1s copying products sold commercially.

Two FDA warning letters have landed on ProRx, an Exton, Pennsylvania outsourcing facility that is FDA-registered as a 503B: one in March 2025, one in April 2026. Voluntary recalls of compounded GLP-1 products have run past 50,000 vials, all for lack of sterility assurance. During the GLP-1 shortage it compounded sterile injections of semaglutide and tirzepatide at scale.

Align Pharmacy sells B2B as a compounding pharmacy, supplying physicians and clinics with customized pharmaceutical formulations. Sterility and potency testing is run on all batches, and the results ship with each preparation. Its public footprint is thin and accreditation badges few, so this entry is data-only for now, pending fuller verification against primary sources.

Brian Williams, PharmD, founded Midtown Express Pharmacy, a Nashville, Tennessee non-sterile compounder, in 2012. Dunklau Pharmacy Holdings, LLC is the legal entity, and licensure covers 32 states and DC. Work spans non-sterile compounded preparations, long-term care and retail, with LDN, hormone and oral weight-management formulations among them. Sterile injectables are NOT compounded here, so no injectable compounded semaglutide or tirzepatide is produced; only oral or sublingual non-injectable forms, if offered.

The regulatory history of Boothwyn Pharmacy, a 503A compounder in Kennett Square, Pennsylvania, is extensive: an FDA warning letter in 2018, a subpotency recall of compounded semaglutide in July 2025, a Pennsylvania fine of $1 million plus probation in 2025 over unlicensed compounding of roughly 30,000 doses of weight-loss drugs, then a further FDA warning letter in January 2026. It had compounded sterile semaglutide and tirzepatide injections. Voluntary suspension of GLP-1 production came in June 2025.

Washington's Department of Health ordered this one to stop. The Limited Stop Service order followed an inspection that reportedly turned up illegally imported bulk GLP-1 ingredient, and patients were moved elsewhere. Before that, the Kirkland 503A facility made injectable semaglutide and tirzepatide.